American Psychological Association 6th edition

Noviandy, T. R., Idroes, G. M., & Hardi, I. (2024). Machine Learning Approach to Predict AXL Kinase Inhibitor Activity for Cancer Drug Discovery Using XGBoost and Bayesian Optimization. Journal of Soft Computing and Data Mining; Vol. 5 No. 1 (2024); 46-56 ; 2716-621 X.

ISO-690 (author-date, English)

NOVIANDY, Teuku Rizky, IDROES, Ghalieb Mutig und HARDI, Irsan, 2024. Machine Learning Approach to Predict AXL Kinase Inhibitor Activity for Cancer Drug Discovery Using XGBoost and Bayesian Optimization. Journal of Soft Computing and Data Mining; Vol. 5 No. 1 (2024); 46-56 ; 2716-621 X. 1 Januar 2024.

Modern Language Association 9th edition

Noviandy, T. R., G. M. Idroes, und I. Hardi. „Machine Learning Approach to Predict AXL Kinase Inhibitor Activity for Cancer Drug Discovery Using XGBoost and Bayesian Optimization“. Journal of Soft Computing and Data Mining; Vol. 5 No. 1 (2024); 46-56 ; 2716-621 X, Januar 2024.

Mohr Siebeck - Recht (Deutsch - Österreich)

Noviandy, Teuku Rizky/Idroes, Ghalieb Mutig/Hardi, Irsan: Machine Learning Approach to Predict AXL Kinase Inhibitor Activity for Cancer Drug Discovery Using XGBoost and Bayesian Optimization, Journal of Soft Computing and Data Mining; Vol. 5 No. 1 (2024); 46-56 ; 2716-621 X 2024,

Emerald - Harvard

Noviandy, T.R., Idroes, G.M. und Hardi, I. (2024), „Machine Learning Approach to Predict AXL Kinase Inhibitor Activity for Cancer Drug Discovery Using XGBoost and Bayesian Optimization“, Journal of Soft Computing and Data Mining; Vol. 5 No. 1 (2024); 46-56 ; 2716-621 X.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.